Tabes Dorsalis: Clinical Trials

3 trials for Tabes Dorsalis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 1 completed. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Recruiting 2

Follow Tabes Dorsalis: new trials by email Literature Review of Tabes Dorsalis trials Research Report on Tabes Dorsalis

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluating VM100 Nutritional Supplement for Improving Quality of Life in Duchenne Muscular Dystrophy Patients
VM100 Nutritional Supplement - Duchenne Muscular Dystrophy, Duchenne Disease
Phase 2RecruitingUniversity of Florida202026-07-272026-10-08
Vasodilator and Exercise Study for DMD (VASO-REx)
Tadalafil, Placebo, Exercise Training - Duchenne Muscular Dystrophy, Duchenne Disease
Phase 2RecruitingUniversity of Florida502024-06-052026-05-15
Biomarker for Duchenne Muscular Dystrophy
Increased Lordosis/Scoliosis, Hyporeflexia
CompletedCENTOGENE GmbH Rostock1032018-08-202022-03-24

Narrower conditions

Muscular Dystrophy, Duchenne (3)  ·  Muscular Dystrophies (2)  ·  Aneurysm (1)  ·  Color Vision Defects (1)  ·  Fatigue (1)  ·  Lordosis (1)  ·  Motor Activity (1)  ·  Muscle Weakness (1)  ·  Muscular Atrophy (1)  ·  Reflex, Abnormal (1)  ·  Scoliosis (1)

Broader conditions

Bacterial Infections (3)  ·  Bacterial Infections and Mycoses (3)  ·  Central Nervous System Bacterial Infections (3)  ·  Central Nervous System Diseases (3)  ·  Central Nervous System Infections (3)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3)  ·  Genetic Diseases, Inborn (3)  ·  Genetic Diseases, X-Linked (3)  ·  Gram-Negative Bacterial Infections (3)  ·  Infections (3)  ·  Muscular Diseases (3)  ·  Muscular Disorders, Atrophic (3)  ·  Musculoskeletal Diseases (3)  ·  Nervous System Diseases (3)  ·  Neuromuscular Diseases (3)

Interventions

Exercise (1)  ·  Tadalafil (1)

Sponsors

University of Florida (2)  ·  CENTOGENE GmbH Rostock (1)

Countries

United States (2)  ·  Albania (1)  ·  Egypt (1)  ·  Georgia (1)  ·  India (1)  ·  Lebanon (1)  ·  Pakistan (1)  ·  Romania (1)  ·  Sri Lanka (1)

Top investigators

Peter Bauer, Prof.Dr (1)  ·  Tanja Taivassalo, MD (1)  ·  Tanja Taivassalo, Ph.D. (1)

NIH funding

R21AR079755 (1)